1. Complete Response to 177 Lu-DOTATATE PRRT in a 9-Year-Old Child With Metastatic Carotid Body Paraganglioma.
- Author
-
Yadav MP, Raju S, Ballal S, and Bal C
- Subjects
- Male, Child, Humans, Positron Emission Tomography Computed Tomography, Octreotide therapeutic use, Radioisotopes, Carotid Body Tumor diagnostic imaging, Carotid Body Tumor radiotherapy, Neuroendocrine Tumors pathology, Organometallic Compounds therapeutic use, Peripheral Nervous System Neoplasms, Head and Neck Neoplasms, Paraganglioma diagnostic imaging, Paraganglioma radiotherapy, Paraganglioma drug therapy
- Abstract
Abstract: We present a case involving a 9-year-old boy diagnosed with metastatic carotid body paraganglioma. The metastases were detected in cervical lymph nodes and lungs using 68 Ga-DOTANOC PET/CT imaging. The patient received peptide receptor radionuclide therapy with 177 Lu-DOTATATE. Following 3 treatment cycles, a significant improvement was observed in the metastatic lesions. After 4 cycles, the patient achieved a complete response, with a cumulative administered activity of 16.65 GBq during the therapy. This case underscores the effectiveness of using 177 Lu-DOTATATE in managing metastatic carotid body paraganglioma, offering promising results in terms of tumor regression and overall therapeutic response., Competing Interests: Conflicts of interest and sources of funding: none declared., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF